FDA’s Hahn Apologizes For Overselling Plasma’s Benefits As A COVID-19 Treatment


Food and Drug Administration Commissioner Stephen Hahn drew a hailstorm of criticism from scientists this week for mischaracterizing a study

The Food and Drug Administration’s chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.

(Image credit: Kevin Dietsch/AP)

Previous articleAll Your Most Pressing Questions About This Year’s Flu Shot, Answered by Health Experts
Next articleI Went on a Road Trip During the Pandemic: Here’s What Did and Didn’t Feel Safe


Please enter your comment!
Please enter your name here